TABLE 5.

Random effects meta-analyses of the efficacy (complete remission (CR)) and safety (early mortality (EM) and veno-occlusive disease (VOD)) of the 6 mg/m² regimen of Mylotarg based on the proposed exact method and the SJ-LGT and SJ-ASIN methods. Presented are the 95% confidence intervals and corresponding lengths for each of the methods

Study	CR	EM	VOD
K	6	5	7
Exact	0.007–0.128 (0.121)	0.049–0.340 (0.291)	0.072–0.367 (0.295)
SJ-LGT	0.027–0.185 (0.158)	0.064–0.342 (0.279)	0.112–0.421 (0.310)
SJ-ASIN	0.003–0.076 (0.073)	0.001–0.252 (0.251)	0.012–0.306 (0.294)
FE	0.004 – 0.121 (0.116)	0.041–0.262 (0.221)	0.105–0.350 (0.245)